Keyphrases
89Zr-bevacizumab
40%
Adult Patients
14%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
40%
Bile Duct
13%
Breast Density Assessment
40%
Circulatory Death
40%
Computed Tomography
40%
Cone-beam Computed Tomography
40%
Donation after Circulatory Death
40%
Early Indicators
40%
Egfr
50%
Everolimus
40%
False Positive Reading
13%
Glomerular Filtration Rate
40%
Growth Rate
20%
Hypothermic Oxygenated Machine Perfusion
40%
Inter-reader
20%
Intraoperative Cone-beam Computed Tomography
40%
Ischemia-reperfusion Injury
26%
Kidney Function
40%
Kidney Growth
30%
Kidney Volume
27%
Liver
13%
Liver Graft
40%
Liver Transplantation
40%
Living Kidney Donor
40%
Locally Advanced Rectal Cancer
40%
Metastatic Renal Cell Carcinoma (mRCC)
40%
Multicenter Randomized Controlled Trial
40%
Neoadjuvant Chemoradiotherapy (nCRT)
15%
Neoadjuvant Therapy
40%
Non-anastomotic Strictures
40%
Percutaneous Nephrolithotomy
40%
Pre-donation
16%
Randomized Controlled Trial
46%
Restaging
40%
Single Kidney
40%
Static Cold Storage
40%
Stone-free Rate
40%
Stone-free Status
24%
SUVmax
30%
T1-weighted Image
20%
T2-weighted Magnetic Resonance Imaging
40%
Total Kidney Volume
40%
Tracer Uptake
15%
Transplantation
13%
Tumor
20%
Volume Measurement
30%
Volume Rate
20%
Zonal Locations
40%
Medicine and Dentistry
Bevacizumab
40%
Bile Duct
11%
Biodistribution
16%
Breast Density
40%
Breast Imaging - Reporting And Data System
10%
Breast Prosthesis
10%
Breast Reconstruction
10%
Carcinoembryonic Antigen
8%
Chemoradiotherapy
40%
Cholestasis
40%
Computer Assisted Tomography
15%
Disease Exacerbation
18%
Distant Metastasis
16%
Everolimus
40%
False Positive Result
40%
Glomerular Filtration Rate
40%
Glomerulus Filtration
40%
Intelligence
10%
Kappa Statistics
20%
Kidney Development
13%
Kidney Function
40%
Kidney Metastasis
40%
Liver Graft
40%
Liver Transplantation
17%
Logistic Regression Analysis
10%
Lymphatic Tissue
16%
Machine Perfusion
40%
Magnetic Resonance Imaging
100%
Metastatic Carcinoma
16%
Neoadjuvant Therapy
40%
Neoplasm
70%
Odds Ratio
10%
Percutaneous Nephrolithotomy
40%
Plasma Half Life
8%
Polycystic Kidney Disease
40%
Positron Emission Tomography
80%
Positron Emission Tomography
13%
Radioactive Tracer
52%
Radiomics
40%
Randomized Controlled Trial
80%
Rectum Cancer
40%
Reperfusion Injury
22%
Risk Evaluation
10%
Solitary Kidney
40%
Standardized Uptake Value
8%
Surgery
8%
T Cell
40%
Total Mesorectal Excision
8%
Volume CT
40%
Zirconium 89
40%
